Literature DB >> 32514709

High Serum Levels of Caspase-3 and Early Mortality in Patients with Severe Spontaneous Intracerebral Hemorrhage.

Leonardo Lorente1, María M Martín2, Antonia Pérez-Cejas3, Agustín F González-Rivero3, Rafael Sabatel4, Luis Ramos5, Mónica Argueso6, Jordi Solé-Violán7, Juan J Cáceres8, Alejandro Jiménez9, Victor García-Marín10.   

Abstract

BACKGROUND: Apoptotic cell death leads to secondary brain injury after spontaneous intracerebral hemorrhage (SIH). There is an association between serum caspase-3 levels and late mortality (at 6 months) in patients with SIH in basal ganglia. The new objective of this study was to determine whether there exists an association between serum caspase-3 levels and early mortality (at 30 days) in patients with SIH at different sites and not only in basal ganglia.
METHODS: Patients with severe supratentorial SIH (defined as Glasgow Coma Scale < 9) admitted in 6 Spanish hospitals were included in this observational and prospective study. Patients with SIH due to aneurysm, arteriovenous malformation, and anticoagulant or fibrinolytic treatment were excluded. Serum caspase-3 levels at days 1, 4, and 8 of SIH were determined. Thirty-day mortality was the end-point study.
RESULTS: Non-surviving (n = 53) showed higher serum caspase-3 levels at days 1 (p < 0.001), 4 (p < 0.001), and 8 (p < 0.001) than survivor patients (n = 64). Multiple logistic regression analysis showed an association of serum caspase-3 levels > 0.167 ng/mL with 30-day mortality (Odds Ratio = 47.007; 95% CI = 4.838-456.727; p = 0.001).
CONCLUSIONS: The new findings of our study are that serum caspase-3 levels are associated with early mortality in patients with severe supratentorial SIH at different sites and that those levels during the first week of SIH are higher in non-survivors than in survivors.

Entities:  

Keywords:  Apoptosis; Caspase-3; Mortality; Patients; Spontaneous intracerebral hemorrhage

Year:  2021        PMID: 32514709     DOI: 10.1007/s12028-020-01012-3

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  5 in total

Review 1.  Therapeutic Potential of Drugs Targeting Pathophysiology of Intracerebral Hemorrhage: From Animal Models to Clinical Applications.

Authors:  Kuo-Hsing Liao; Chih-Wei Sung; Ya-Ni Huang; Wei-Jiun Li; Po-Chuan Yu; Jia-Yi Wang
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

2.  [Study of relationship between inflammatory response and apoptosis in perihematoma region in patients with intracerebral hemorrhage].

Authors:  Fu-qiang Guo; Xiao-jia Li; Long-yi Chen; Hong Yang; Hong-yuan Dai; Yong-sheng Wei; Yu-lan Huang; You-song Yang; Hong-bin Sun; Yu-chuan Xu; Zheng-lin Yang
Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue       Date:  2006-05

3.  Simvastatin improves intracerebral hemorrhage through NF-κB-mediated apoptosis via the MyD88/TRIF signaling pathway.

Authors:  Chengyao Gu; Yunqin Wu; Zhenyi Fan; Weiwei Han
Journal:  Exp Ther Med       Date:  2017-10-23       Impact factor: 2.447

4.  [Neural apoptosis and apoptosis-related genes in intracerebral hemorrhage patients].

Authors:  Cheng-han Wu; Xi-yan Ding; Hai-yan Wang; Xiao-bao Ye; Sheng-yue Huang; Ai-min Huang; Hui-zhong Li; Song-ying Wu; Ji Yu; Xiao-hua Yan
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2006-11-21

5.  Apoptosis as a form of cell death in intracerebral hemorrhage.

Authors:  Adnan I Qureshi; M Fareed K Suri; Peter T Ostrow; Stanley H Kim; Zulfiqar Ali; Ahmed A Shatla; Lee R Guterman; L Nelson Hopkins
Journal:  Neurosurgery       Date:  2003-05       Impact factor: 4.654

  5 in total
  1 in total

1.  Plasma D-dimer predicts poor outcome and mortality after spontaneous intracerebral hemorrhage.

Authors:  Qi Zhou; Daming Zhang; Xin Chen; Zhao Yang; Zhihui Liu; Baixing Wei; Mei Jin; Kairu Feng; Chunmei Guo; Junying Sun; Sheng Chen; Ruijia Zhang; Xiai Piao; Ilgiz Gareev; Zhenying Sun; Xiaoxiong Wang; Lili Li; Shiguang Zhao; Guang Yang
Journal:  Brain Behav       Date:  2020-11-11       Impact factor: 2.708

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.